Pyridine substituted furan derivatives as raf kinase inhibitors
A Standard patent application filed on 05 September 2002 credited to Wilson, David Matthew
;
Takle, Andrew Kenneth
Details
Application number :
2002339507
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Pyridine substituted furan derivatives as raf kinase inhibitors
Inventor :
Wilson, David Matthew
;
Takle, Andrew Kenneth
Agent name :
Address for service :
Filing date :
05 September 2002
Associated companies :
Applicant name :
DEAN, David, Kenneth
Applicant address :
GlaxoSmithKline, New Frontiers Science Park South, Third Avenue, Harlow, Essex CM19 5AW